Author Archive: Jessica Torres

Jessica Torres

Jessica is a Marketing & Web Content Coordinator in the Business Development department at BIO. She keeps all the content for the Business Development conference event web pages up to date, optimizes email marketing campaigns to increase open and click-through rates, and leverages emerging social media tools to increase engagement among attendees at industry conferences and events. After a long day of marketing and social media, she goes home and blogs about marketing and social media on her personal website www.getstuckintraffic.com, and on Twitter.

Latest Posts

Nasdaq Social Bell: Twitter Strategies For Biotechs

Nasdaq Social Bell

Last week at the BIO CEO & Investor Conference in New York City, I had the pleasure of speaking with John Machiz and Brad Smith from Nasdaq at their headquarters in Times Square to discuss the social media activity that happened onsite during the event, what made the discussion of the event online so robust, and what biotech companies can do to increase their visibility on Twitter. View the video below, and get a recap of the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Kaylee_dna_115x76

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, “Trust Your Gut” – Therapeutic Opportunities from the Microbiome. The panel was moderated by Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co. The panelists were: Martin J. Blaser, MD, Muriel and George Singer Professor of Medicine, Professor of Microbiology, Director, Human Microbiome Program, New York University Langone Medical Center Karim Dabbagh, PhD, Chief Scientific Officer, Second Genome Michael Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Session Recap: Digital Health—Early Successes for Investors and Biotech R&D Productivity

shutterstock_27160801

Digital health has the potential to improve the life science industry by combining traditional and novel medicines with digital technologies, enabling the life sciences to become more patient-centered as well as accelerating product discovery. There is growing interest in digital health among investors as new data and technologies become available that fill unmet needs in the marketplace. At the 17th Annual BIO CEO & Investor Conference, a panel of digital health experts came together to Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Electroceuticals and Digital Drug Delivery: Neurological Stimulation and Beyond

electroceuticals panel

Some of the most experienced executives in biotechnology have begun asking themselves, “Can we foresee the day of diminishing returns from research in traditional molecular biology?” These researchers are investigating alternative modalities of providing therapy that would combine electronic sensing with drug delivery or even stimulating the body through electricity alone to produce a desired response. These “electroceutical,” or “bioelectronics,” approaches have produced exciting results in early clinical trials, particularly related to insulin control and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Fireside Chat with Ken Drazan, MD, Head of Johnson & Johnson Innovation

Ken Drazan, MD

Day one of the BIO Investor Forum featured a Fireside Chat with Ken Drazan, MD, who serves as the head of Johnson & Johnson Innovation in California. The conversation was moderated by Deepa R. Pakianathan, PhD, a general partner for Delphi Ventures who leads the firm’s biotechnology investment activities. Ken Drazan has a unique viewpoint which results from having experience with both the biopharma start-up world as well as in the investment community. This background Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,